š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Clindamycin 1.0% - tretinoin 0.025% gel (CT Gel) is a reformulation of VELA...
Status
Completed
Location
Multiple Locations
Start Date
2008-12-08
Trial ID
NCT01929278
Treatments Being Tested
The objective of the trial is to investigate efficacy and safety of ingenol...
Status
Completed
Location
Laser & Skin Surgery Center of Indiana
Start Date
2015-04
Trial ID
NCT02361216
Treatments Being Tested
The study will assess safety and tolerability of different doses of topical...
Status
Completed
Location
KGL, Inc
Start Date
2012-09
Trial ID
NCT01694810
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of AC...
Status
Completed
Location
Radiant Research
Start Date
2005-11
Trial ID
NCT00249782
Oral lichen planus (OLP) is a chronic inflammatory mucocutaneous disease ch...
Status
Completed
Location
Pia Lopez Jornet
Start Date
2014-01
Trial ID
NCT02421770
Treatments Being Tested
The study is a two part study, designed to validate safety results from the...
Status
Completed
Location
California Dermatology & Clinical Research Institute
Start Date
2024-06-05
Trial ID
NCT06393452
Treatments Being Tested
The purpose of this study is to determine whether a glaucoma therapy is saf...
Status
Completed
Location
United States Investigative Sites in Texas and Other States
Start Date
2005-11
Trial ID
NCT00287521
This study is being conducted to determine the potential of Ibuprofen 5% To...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-01
Trial ID
NCT01787448
This is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded,...
Status
Recruiting
Location
University of California, San Diego: Dermatology Clinical Trials Unit
Start Date
2025-05-22
Trial ID
NCT06504160
This is a multi-center, open label long-term safety (LTS) study to be condu...
Status
Completed
Location
CIL #138
Start Date
2016-05-12
Trial ID
NCT02798120
Treatments Being Tested